- Home
- IBG vs EKSO Comparison
IBG vs EKSO Comparison
Compare IBG & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | EKSO |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.7M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | IBG | EKSO |
|---|---|---|
| Price | $2.56 | $4.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 271.8K | ★ 319.2K |
| Earning Date | 05-12-2026 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,931,243.00 | ★ $14,749,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $54.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.48 | $2.73 |
| 52 Week High | $9.85 | $14.97 |
Technical Indicators
Market Signals| Indicator | IBG | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 55.20 |
| Support Level | $2.36 | $3.50 |
| Resistance Level | $2.75 | $4.51 |
| Average True Range (ATR) | 0.34 | 0.41 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 58.87 | 95.83 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.